POC1A

POC1A is a WD40-domain centriolar protein that, together with its paralog POC1B, forms heterodimers within the centriole lumen to organize an inner scaffold interaction network—including POC5, FAM161A, and MDM1—that is essential for centriole integrity and stability (PMID:39543170). POC1A localizes to centrioles and spindle poles throughout the cell cycle, where it is required for centriole biogenesis, ciliogenesis, proper mitotic spindle organization, and centrosome-dependent Golgi assembly and membrane trafficking; its loss causes supernumerary centrosomes, multipolar spindles, impaired ciliogenesis, Golgi dispersal, and defective retrograde trafficking (PMID:22840364, PMID:23015594, PMID:22840363). In vivo, Poc1a disruption impairs skeletal growth plate organization, spermatogenesis, and ciliary function, and in human cells its loss additionally induces cellular senescence and resistance to insulin/IGF-1 signaling through altered receptor localization (PMID:26496357, PMID:38245004). Biallelic loss-of-function mutations in POC1A cause SOFT syndrome (short stature, onychodysplasia, facial dysmorphism, and hypotrichosis), a primordial dwarfism disorder linked to centrosome dysfunction (PMID:22840364, PMID:22840363).

1. 2012 High

   Establishing that POC1A is a centriolar/spindle-pole protein whose depletion disrupts ciliogenesis and mitotic spindle architecture resolved its basic subcellular role and linked it to centrosome function.

   Evidence siRNA knockdown in human fibroblasts with immunofluorescence and ciliogenesis assays; parallel isoform-specific RNAi depletion with live-cell imaging showing POC1A and POC1B are redundant for centriole integrity

   PMID:22840364 PMID:23015594

   Open questions at the time

   • Molecular basis of POC1A versus POC1B redundancy at the centriole was unclear
   • No structural information on how POC1A integrates into centriole architecture
   • Mechanism by which POC1A loss leads to multipolar spindles was not resolved
2. 2012 Medium

   Patient-derived fibroblasts carrying a POC1A missense mutation revealed that centrosome dysfunction propagates to Golgi dispersal and impaired retrograde membrane trafficking, expanding POC1A's functional scope beyond the centrosome itself.

   Evidence Patient fibroblasts with p.Leu171Pro mutation analyzed by immunofluorescence of centrosomes and Golgi, cholera-toxin trafficking assay

   PMID:22840363

   Open questions at the time

   • Single-family study; mutation-specific effects versus general POC1A loss not distinguished
   • Whether trafficking defect is a direct consequence of Golgi dispersal or an independent POC1A function was unresolved
3. 2015 High

   In vivo disruption of Poc1a in mice confirmed its necessity for ciliogenesis, spindle fidelity, spermatogenesis, and growth plate chondrocyte organization, establishing systemic physiological consequences of POC1A loss.

   Evidence Mouse model with retrotransposon insertion in Poc1a; fibroblast ciliogenesis, histology, and spermatogonial transplantation

   PMID:26496357

   Open questions at the time

   • Molecular partners mediating the growth plate phenotype were not identified
   • Relationship between cilia defects and skeletal phenotype not causally dissected
4. 2015 Medium

   Analysis of additional patient mutations linked POC1A deficiency to centrosome amplification and suggested a functional connection with p80-katanin, while also revealing context-dependent compensation in ciliogenesis.

   Evidence Patient fibroblasts with p.T120A missense or frameshift mutations; centrosome counting, gene expression arrays, primary cilia assays

   PMID:26162852 PMID:26336158

   Open questions at the time

   • POC1A–katanin interaction was inferred from expression changes, not validated by direct binding assays
   • Mechanism of centrosome clustering compensation was not elucidated
5. 2024 High

   Structural and interaction mapping revealed that POC1A–POC1B heterodimers organize the centriole inner scaffold by positioning POC5 tetramers via FAM161A and MDM1, resolving the molecular architecture underlying POC1A's role in centriole stability.

   Evidence Co-immunoprecipitation, STED/expansion microscopy, cryo-ET, single and double gene knockouts, domain mapping in human cells

   PMID:39543170

   Open questions at the time

   • Atomic-resolution structure of the POC1A–POC1B heterodimer is not available
   • How disease-causing point mutations disrupt specific interaction interfaces was not mapped
6. 2024 Medium

   POC1A loss was shown to impair adipocyte differentiation, induce senescence, and cause insulin/IGF-1 signaling resistance via mislocalization of insulin receptors, linking centrosome/cilia dysfunction to metabolic phenotypes seen in SOFT syndrome patients.

   Evidence CRISPR-deleted human adipose stem cells and patient fibroblasts; ciliogenesis, adipogenesis, senescence, and receptor localization assays

   PMID:38245004

   Open questions at the time

   • Whether insulin receptor mislocalization is cilia-dependent or centrosome-dependent is unclear
   • In vivo metabolic validation in animal models was not performed
7. 2025 Medium

   POC1A was found to promote EMT and metastasis in triple-negative breast cancer through STAT3 pathway activation, revealing a gain-of-function role in cancer distinct from its developmental loss-of-function phenotypes.

   Evidence RNA-seq, functional invasion/migration assays, and xenograft models in breast cancer cell lines with STAT3 inhibition rescue

   PMID:40830747

   Open questions at the time

   • Mechanism by which a centriolar structural protein activates STAT3 signaling is unknown
   • Single cancer type studied; generalizability not assessed
   • Direct physical interaction between POC1A and STAT3 pathway components not demonstrated

• How POC1A disease mutations perturb specific interaction interfaces within the inner scaffold network, and whether the metabolic and cancer-related phenotypes are mechanistically linked to centriole/cilia dysfunction or represent independent functions, remain unresolved.
• No atomic-resolution structure of POC1A or disease-mutant variants exists
• Causal relationship between cilia loss and insulin signaling defects not established
• POC1A's STAT3-activating mechanism is entirely uncharacterized